pmvp: the income statement

MyFinsight

PMV Pharmaceuticals, Inc. (PMVP)

For the quarter ending 2025-06-30, PMVP made $1,690K in revenue. -$21,273K in net income. Net profit margin of -1258.76%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Foreign currency translation (loss) gain	-2
Unrealized (loss) on available for sale investments, net of tax	-61
Provision (benefit) for income taxes	5
Interest income, net	1,690
Other expense, net	-16
Total other income	1,674
Total research and development	18,400
Total general and administrative	4,479
Total operating expenses	22,879
Loss from operations	-22,879
Loss before provision (benefit) for income taxes	-21,205
Net loss	-21,210
Total comprehensive loss	-21,273

Earnings per share, basic, total	-0.41
Earnings per share, diluted, total	-0.41
Weighted average number of shares outstanding, basic, total	52,010,827
Weighted average number of shares outstanding, diluted, total	52,010,827

Unit: Thousand (K) dollars (except for numbers of shares and EPS)